The Effects of Multidisciplinary Intensive Rehabilitation on Cognitive and Executive Functions in Parkinson's Disease: A Clinical Database Analysis

Overview

Journal J Clin Med

Specialty General Medicine

Date 2024 Jul 13

PMID 38999450

Authors

Ivana Baldassarre

Rossella Rotondo

Laura Piccardi

Lorenza Leonardi

Danilo Lanni

Maria Gaglione

Fabrizio Stocchi

Massimo Fini

Michela Goffredo

Elvira Padua

Maria Francesca De Pandis

Affiliations

Soon will be listed here.

Abstract

This study is based on data collected from a medical health record review to assess whether multidisciplinary intensive rehabilitation treatment in Parkinson's disease (PD) patients can improve global cognitive functioning and executive functions. : The data related to PD patients were extrapolated from a clinical database called "NeuroRehab". A total of 104 PD patients (51 males; 53 females) performed 6 weeks of multidisciplinary intensive rehabilitation treatment in clinical practice from January 2019 to May 2023. This training program was characterized by three daily sessions of 60 min of activities (muscle relaxation and stretching exercises, moderate physical aerobic exercise, and occupational therapy). The patients were classified and stratified according to disease severity (according to the Hoehn and Yahr scale), postural instability and gait difficulty (PIGD) or tremor-dominant (TD) subtypes, disease duration (DD), and the presence of dyskinesias. The effect of multidisciplinary intensive rehabilitation treatment on cognitive and executive functions was evaluated through the administration of cognitive tests, such as the Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and Frontal Assessment Battery (FAB). All the parameters were evaluated at the baseline (T0) and at the end of the rehabilitation program (T1). : The multidisciplinary intensive rehabilitation treatment significantly improved cognitive performance. The MMSE, MoCA, and FAB test scores after the rehabilitation program (T1) were significantly higher compared to the scores obtained at the baseline (T0). Moreover, further analyses on subgroups of the patients who scored below the cut-off in the MMSE showed that at least 50% of patients overcame the cut-off score. Interestingly, the same analyses performed for the MoCA and FAB revealed a higher rate of improvement in cognitive functions, with normal scores in both tests after 6 weeks of multidisciplinary intensive rehabilitation treatment. : This study revealed the potential effects of a 6-week multidisciplinary rehabilitation program in improving cognitive status in a PD inpatient cohort.

References

Kim R, Lee T, Lee H, Ko D, Lee J, Shin H . Effects of physical exercise interventions on cognitive function in Parkinson's disease: An updated systematic review and meta-analysis of randomized controlled trials. Parkinsonism Relat Disord. 2023; 117:105908. DOI: 10.1016/j.parkreldis.2023.105908. View

Roheger M, Kalbe E, Liepelt-Scarfone I . Progression of Cognitive Decline in Parkinson's Disease. J Parkinsons Dis. 2018; 8(2):183-193. PMC: 6004891. DOI: 10.3233/JPD-181306. View

. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018; 18(1):88-106. PMC: 6291454. DOI: 10.1016/S1474-4422(18)30403-4. View

Larner A . Screening utility of the Montreal Cognitive Assessment (MoCA): in place of--or as well as--the MMSE?. Int Psychogeriatr. 2011; 24(3):391-6. DOI: 10.1017/S1041610211001839. View

Saredakis D, Collins-Praino L, Gutteridge D, Stephan B, Keage H . Conversion to MCI and dementia in Parkinson's disease: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2019; 65:20-31. DOI: 10.1016/j.parkreldis.2019.04.020. View

. Global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018; 17(12):1083-1097. PMC: 6234315. DOI: 10.1016/S1474-4422(18)30404-6. View

Dong Y, Yean Lee W, Basri N, Collinson S, Merchant R, Venketasubramanian N . The Montreal Cognitive Assessment is superior to the Mini-Mental State Examination in detecting patients at higher risk of dementia. Int Psychogeriatr. 2012; 24(11):1749-55. DOI: 10.1017/S1041610212001068. View

Prime M, McKay J, Bay A, Hart A, Kim C, Abraham A . Differentiating Parkinson Disease Subtypes Using Clinical Balance Measures. J Neurol Phys Ther. 2019; 44(1):34-41. PMC: 6991154. DOI: 10.1097/NPT.0000000000000297. View

Antonini A, Barone P, Marconi R, Morgante L, Zappulla S, Pontieri F . The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. J Neurol. 2012; 259(12):2621-31. DOI: 10.1007/s00415-012-6557-8. View

10.

Ray Dorsey E, Sherer T, Okun M, Bloem B . The Emerging Evidence of the Parkinson Pandemic. J Parkinsons Dis. 2018; 8(s1):S3-S8. PMC: 6311367. DOI: 10.3233/JPD-181474. View

11.

Meloni M, Saibene F, Di Tella S, Di Cesare M, Borgnis F, Nemni R . Functional and Cognitive Improvement After an Intensive Inpatient Multidisciplinary Rehabilitation Program in Mild to Severe Parkinson's Disease: A Retrospective and Observational Study. Front Neurol. 2021; 12:626041. PMC: 8012662. DOI: 10.3389/fneur.2021.626041. View

12.

Litvan I, Goldman J, Troster A, Schmand B, Weintraub D, Petersen R . Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012; 27(3):349-56. PMC: 3641655. DOI: 10.1002/mds.24893. View

13.

Santangelo G, Siciliano M, Pedone R, Vitale C, Falco F, Bisogno R . Normative data for the Montreal Cognitive Assessment in an Italian population sample. Neurol Sci. 2014; 36(4):585-91. DOI: 10.1007/s10072-014-1995-y. View

14.

Ren J, Hua P, Li Y, Pan C, Yan L, Yu C . Comparison of Three Motor Subtype Classifications in Parkinson's Disease Patients. Front Neurol. 2021; 11:601225. PMC: 7785849. DOI: 10.3389/fneur.2020.601225. View

15.

Herman T, Weiss A, Brozgol M, Giladi N, Hausdorff J . Gait and balance in Parkinson's disease subtypes: objective measures and classification considerations. J Neurol. 2014; 261(12):2401-10. DOI: 10.1007/s00415-014-7513-6. View

16.

Dauwan M, Begemann M, Slot M, Lee E, Scheltens P, Sommer I . Physical exercise improves quality of life, depressive symptoms, and cognition across chronic brain disorders: a transdiagnostic systematic review and meta-analysis of randomized controlled trials. J Neurol. 2019; 268(4):1222-1246. PMC: 7990819. DOI: 10.1007/s00415-019-09493-9. View

17.

Schapira A, Chaudhuri K, Jenner P . Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017; 18(7):435-450. DOI: 10.1038/nrn.2017.62. View

18.

Burn D, Rowan E, Allan L, Molloy S, OBrien J, McKeith I . Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2006; 77(5):585-9. PMC: 2117449. DOI: 10.1136/jnnp.2005.081711. View

19.

Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L . Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology. 1990; 40(10):1529-34. DOI: 10.1212/wnl.40.10.1529. View

20.

Alves G, Larsen J, Emre M, Wentzel-Larsen T, Aarsland D . Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord. 2006; 21(8):1123-30. DOI: 10.1002/mds.20897. View